Perinatal and Delivery Outcomes Following Amniocentesis: A Case-Control Study in the Polish Population
- PMID: 39860315
- PMCID: PMC11766295
- DOI: 10.3390/jcm14020309
Perinatal and Delivery Outcomes Following Amniocentesis: A Case-Control Study in the Polish Population
Abstract
Background: Amniocentesis is a widely used invasive prenatal diagnostic procedure, recognized for its high sensitivity and low risk of complications. This study aims to evaluate the association between amniocentesis and pregnancy outcomes, such as miscarriage, preterm rupture of membranes (PROM), and preterm birth, as well as perinatal outcomes. Methods: A case-control study was conducted at the Regional Hospital in Kielce, Poland, from 2016 to 2022, involving 1834 patients, 225 of whom underwent amniocentesis, while 1609 did not receive any invasive diagnostics. Data were collected from medical records and included maternal factors such as age, BMI, delivery mode, complications, and newborn condition. Results: The study found no statistically significant differences between the study and the control groups regarding pregnancy or perinatal characteristics. Miscarriage occurred in 1.9% of the patients in the amniocentesis group, with no cases in the control group. Rates of preterm delivery were similar between groups (8.33% in the study group vs. 5.74% in the control group, p > 0.05). Postnatal outcomes, such as birth term, birth weight, and Apgar scores, were comparable across both groups. Fetal growth restriction was slightly more frequent in the study group (2.8% vs. 0.8%). One neonatal death was observed in each group. The relative risk of complications following amniocentesis was 1.69 (CI 0.38-7.24). Conclusions: Amniocentesis is a safe invasive prenatal procedure. It should be offered to every pregnant woman when necessary. Before the procedure, the patient should be clearly informed of the risk related to amniocentesis but at the same time reassured that the complication rate is very low.
Keywords: genetic counseling; prenatal care; prenatal diagnosis; prenatal screening.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Amniocentesis compared with antenatal corticosteroids prior to early term scheduled cesarean delivery.J Matern Fetal Neonatal Med. 2019 Nov;32(21):3571-3576. doi: 10.1080/14767058.2018.1468431. Epub 2018 May 6. J Matern Fetal Neonatal Med. 2019. PMID: 29681180
-
Comparative analysis of obstetric, perinatal, and neurodevelopmental outcomes following chorionic villus sampling and amniocentesis.Front Med (Lausanne). 2024 Jun 28;11:1407710. doi: 10.3389/fmed.2024.1407710. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39005648 Free PMC article.
-
Complication rates after chorionic villus sampling and midtrimester amniocentesis: A 7-year national registry study.J Formos Med Assoc. 2019 Jul;118(7):1107-1113. doi: 10.1016/j.jfma.2019.03.006. Epub 2019 Mar 27. J Formos Med Assoc. 2019. PMID: 30928186
-
Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis.Am J Obstet Gynecol MFM. 2020 May;2(2):100107. doi: 10.1016/j.ajogmf.2020.100107. Epub 2020 Mar 25. Am J Obstet Gynecol MFM. 2020. PMID: 32292902 Free PMC article.
-
Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis.Ultrasound Obstet Gynecol. 2019 Oct;54(4):442-451. doi: 10.1002/uog.20353. Epub 2019 Sep 6. Ultrasound Obstet Gynecol. 2019. PMID: 31124209
References
-
- Gucciardo L., Ochsenbein-Kölble N., Ozog Y., Verbist G., Van Duppen V., Fryns J.P., Lories R., Deprest J. A Comparative Study on Culture Conditions and Routine Expansion of Amniotic Fluid-Derived Mesenchymal Progenitor Cells. Fetal Diagn. Ther. 2013;34:225–235. doi: 10.1159/000354895. - DOI - PubMed
-
- Chang Y.-W., Chang C.-M., Sung P.-L., Yang M.-J., Li W.H., Li H.-Y., Chen L.-C., Cheng L.-Y., Lai Y.-L., Cheng Y.-Y., et al. An overview of a 30-year experience with amniocentesis in a single tertiary medical center in Taiwan. Taiwan. J. Obstet. Gynecol. 2012;51:206–211. doi: 10.1016/j.tjog.2012.04.007. - DOI - PubMed
LinkOut - more resources
Full Text Sources